Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SARS-Cov-2 inhibitors (covid-19)

Home DrugsSARS-Cov-2 inhibitors (covid-19)

SARS-Cov-2 inhibitors (covid-19)

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Inhibitors for coronavirus
Applicant: SOUTHWEST RES INSTPriority: 2022
US
Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof
Applicant: UNIV ARIZONAPriority: 2020
US
WO
3 publications
KETOAMIDE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
Applicant: WESTVAC BIOPHARMA CO LTDPriority: 2022
EP
US
2 publications
Drugs for resisting novel coronavirus SARS-CoV-2 and application thereof
Applicant: INST PATHOGEN BIOLOGY CAMSPriority: 2020
CN
1,2,4-TRIOXANE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR USE IN THE TREATMENT OF COVID-19
Applicant: ARTEMIFLOW GMBHPriority: 2020
EP
ENZYME INHIBITORS AND VIRAL INFECTION THERAPY
Applicant: FENG PINGHUIPriority: 2022
US
Antivirus proteins having a Kringle 5 subunit
Applicant: CREATIVE BIOTHERAPEUTICS LLCPriority: 2021
CN
EP
US
WO
6 publications
Protease inhibitors for treatment of coronavirus infections
Applicant: SCRIPPS RESEARCH INSTPriority: 2021
CN